MethylGene Inc.
Profile
Mailing Address: 9363 Towne Centre Drive, Suite 200
San Diego, California
92121
Head Office Address: 9363 Towne Centre Drive, Suite 200
San Diego, California
92121
Contact Name: Mark J. Gergen, Executive Vice President & COO Principal Regulator: Quebec
Business e-mail address: gergenm@MIRATI.COM Short Form Prospectus Issuer: Yes
Telephone Number: 858 546-2902 Reporting Jurisdictions: Ceased Reporting
Fax Number: Stock Exchange: N/A
Date of Formation: May 19 2010 Stock Symbol:
Jurisdiction Where Formed: Canada Auditor: ERNST & YOUNG
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 591545 Transfer Agent: Computershare Investor Services Inc.
Financial Year-End: Dec 31 Size of Issuer (Assets): $25,000,001 to $100,000,000


This company is a previous issuer to   Mirati Therapeutics, Inc.
View This Company's Documents